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Edited by Horst FeldmannAbstract In the ubiquitin-proteasome system, substrates fated
for destruction ﬁrst acquire covalent modiﬁcation by ubiquitin,
and are subsequently destroyed by the proteasome. Tradition-
ally, 26S proteasomes have been seen as largely uniform in their
composition and functional capacity. Accordingly, cells can con-
trol proteasome abundance via transcriptional pathways that
mediate concerted regulation of all known proteasome genes.
However, recent evidence suggests that the proteasome is also
subject to subunit-speciﬁc modes of regulation, which serve to al-
ter proteasome function and may generate ensembles of compo-
sitionally distinct proteasomes. These modes of proteasome
regulation provide varied means to adapt protein degradation
pathways to changing conditions in the cell.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Ubiquitin; Proteasome; Stress; Rpn4; AIRAP;
Ubp61. The ubiquitin-proteasome system for protein degradation
The ubiquitin-proteasome system represents the major path-
way for intracellular protein degradation in eukaryotes. Sub-
strates are designated for destruction in this pathway by the
covalent attachment of a polyubiquitin chain. The generation
of such polyubiquitin chains requires the activity of three clas-
ses of enzymes [1]. A ubiquitin molecule is ﬁrst activated for
transfer via formation of a thiolester bond with the ubiquitin
activating enzyme, or E1. This activated ubiquitin is then
transferred to a ubiquitin conjugating enzyme, or E2, again
via formation of a thiolester bond. Typically, the activated
ubiquitin molecule is then transferred to the substrate in col-
laboration with a ubiquitin ligase, or E3. Two general para-
digms for ubiquitin ligation exist. In the ﬁrst, the E2
transfers the ubiquitin molecule to the E3, which possesses
its own catalytic activity and is responsible for ultimate trans-
fer of ubiquitin to substrate. In the second, the E3 functions
non-catalytically with E2 to promote ubiquitin transfer.
Ubiquitin itself is a highly conserved 76 amino acid protein
which invariably ends in a diglycine motif. A covalent bond is
formed between ubiquitin and substrate typically via the car-
boxyl group of the terminal glycine in ubiquitin and the e-ami-*Corresponding author. Fax: +1 617 432 1144.
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commonly, other nucleophiles may be modiﬁed by ubiquitina-
tion. Polyubiquitin chain formation proceeds typically via iso-
peptide bond formation between the G76 carboxyl group of
the ‘‘n + 1’’ ubiquitin to the e-amino group of a lysine within
the preceding ubiquitin. Seven lysines are found in ubiquitin,
allowing for the generation of a variety of polyubiquitin chain
types [2]. Preventing ubiquitin chain formation abrogates or
attenuates the degradation of many substrates (e.g., see Ref.
[3]). The minimum length of a polyubiquitin chain capable
of supporting degradation appears to be approximately four
[4], although many substrates appear to acquire polyubiquitin
chains that are signiﬁcantly longer.
The fundamental role of the substrate-linked polyubiquitin
chain is to serve as a recognition motif for a large multi-sub-
unit protease known as the proteasome, which is responsible
for hydrolyzing the substrate’s peptide bonds, thereby reduc-
ing a folded protein into oligopeptides. Other proteases con-
vert these peptide products into free amino acids, which can
then be used anew in biosynthetic processes.
The proteasome is an approximately 2.5-MDa protein com-
plex thought to consist of at least 33 subunits in the budding
yeast Saccharomyces cerevisiae [5]. The proteasome can be di-
vided by biochemical methods into two smaller complexes
(Fig. 1). The ﬁrst is the 670 kDa core particle, also known as
CP or the 20S particle. The CP is a barrel-shaped complex con-
sisting of four stacked rings, each ring composed of seven pro-
teins [6]. The two outer rings are identical, as are the two inner
rings, giving the CP an ‘‘abba’’ conﬁguration along a vertical
axis, as well as a sevenfold pseudo-symmetry within each ring
of subunits. The peptidolytic active sites of the proteasome are
sequestered within a cavity formed at the center of the CP by
the two inner (beta) rings [6]. There are three distinct peptido-
lytic activities in the CP, each represented twice: a tryptic activ-
ity (i.e. cleaving after basic residues), a chymotryptic activity
(i.e. cleaving after hydrophobic residues), and a post-acidic
activity [7]. On either side of the central cavity is a second cav-
ity formed between an inner (beta) and an outer (alpha) ring,
but the exact function of these outer chambers remains un-
known. Substrates gain access to the CP only though narrow
pores present at either axial end of the CP and structurally rep-
resented by the N-termini of alpha ring subunits [8]. Impor-
tantly, the pores leading to the interior of the CP are shut in
the basal state, and require a mechanism of gate opening to
facilitate substrate degradation. This function, among others,
is carried out by the second subcomplex of the proteasome:
the regulatory particle, also known as the RP or 19S particle
or PA700.blished by Elsevier B.V. All rights reserved.
Fig. 1. Schematic representation of the 26S proteasome. The canonical
26S proteasome is composed of one core particle and one or two
regulatory particles, as indicated. The regulatory particle can be
further subdivided into the lid and the base. The base contains six
ATPases (Rpt1-6), and three non-ATPase subunits. The lid contains
six PCI domain-containing proteins (Rpn3, Rpn5–7, Rpn9, and
Rpnl2), two MPN domain-containing protein (Rpn8 and Rpn11),
and one additional protein, Rpnl5 (also known as Sem1). Adapted
from [5], with permission.
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proteins. One RP may associate with either axial end of the
CP. When the CP is associated with one or two RP species,
the complex is referred to as the 26S proteasome. The RP
may be further divided by biochemical means into two sub-
complexes of its own, the base and the lid [9]. The base sub-
complex is located proximal to the CP and contains six
AAA-type ATPases (Rptl-6) as well as four non-ATPase sub-
units (Rpn1, Rpn2, Rpn10, and Rpn13). The six ATPases of
the base are thought to form a ring, as well as to possess a pro-
tein remodeling capacity presumed to function in substrate
unfolding [10,11]. The pore leading into the CP is too narrow
to be traversed by most folded proteins, and as such, unfolding
is thought to be a prerequisite for the degradation of the
majority of proteasome substrates. Despite very high sequence
similarity among the six ATPases, early work demonstrated
their non-equivalence of function [12], and delineating their
precise roles remains an active area of investigation. One ATP-
ase, Rpt2, is known to play a role in opening the pore into the
CP to facilitate substrate entry [13], while Rpt5 is thought to
play a role in recognition of the substrate-bound ubiquitin
chain [14]. Another base component, Rpn10, is clearly a ubiq-
uitin receptor [15,16]. The functions of Rpn1 and Rpn2, which
represent two of the largest proteins of the proteasome, have
remained more elusive. Rpn1 is known to bind a series of ubiq-
uitin chain receptors which are not core components of the
proteasome, but rather, substoichiometrically-associating pro-
teins [17,18]. These proteins – Rad23, Dsk2, and Ddil – share a
common domain at their respective N-termini known as a
ubiquitin-like domain, and this domain mediates recognition
by Rpn1. An unrelated protein, the deubiquitinating enzyme
Ubp6, also contains an N-terminal ubiquitin-like domain,
and is recognized by Rpn1 (see below). The functions ofRpn2 remain even more obscure, but Rpn2 is known to bind
a HECT-domain containing ubiquitin ligase known as Hul5
[19].
The lid subcomplex of the RP is found distal to the base and
was originally characterized as an eight-component complex
with high sequence homology to two other cellular complexes,
the COP9 signalosome and translation initiation factor eIF3
[9]. All three complexes are characterized by two protein mo-
tifs known as the MPN and PCI domains [9]. The lid possesses
six PCI-domain-containing subunits (Rpn3, Rpn5-7, Rpn9,
and Rpn12) and two MPN domain proteins (Rpn8 and
Rpn11). The PCI domain remains poorly understood, but
the MPN domain of Rpn11 is known to represent a metallo-
protease-like deubiquitinating activity which removes ubiqui-
tin from substrates [20–22]. A corresponding activity in the
COP9 signalosome removes the ubiquitin-like modiﬁer Nedd8
from the cullin subunits of various protein complexes [23]. No
such activity has yet been identiﬁed in eIF3. The MPN domain
of Rpn8 is very similar to that of Rpn11, but lacks crucial cat-
alytic residues. In recent years, a ninth member of the lid, Sem1
or Rpn15, has been identiﬁed [5].
Initial characterization of the lid demonstrated its necessity
for the degradation of ubiquitin conjugates, in contrast to
base-CP molecules, which were competent for the degradation
of at least some non-ubiquitinated substrates [9]. The precise
basis for this requirement for the lid remains unclear, but
may reﬂect, at least in part, the activity of Rpn11 in releasing
ubiquitin chains from substrates prior to degradation (see be-
low).
Thus the proteasome is an unusually complex protease, har-
boring, in addition to the CP-enclosed active sites, a number of
catalytic and non-catalytic activities which facilitate the unique
aspects of its function. Potential substrates must ﬁrst be recog-
nized and bound by ubiquitin receptors in the RP. Substrates
must be unfolded and threaded through the pore into the CP,
which can occur only after the gate leading to the CP has been
opened. Finally, at some point prior to degradation, the ubiq-
uitin molecules, which serve to target the substrate to the pro-
teasome, must themselves be released for reuse.2. Regulation of both the magnitude and nature of proteasome
function
The proteasome functions in a wide array of cellular pro-
cesses, many of them essential for viability. As such, the cell
is presumably under pressure to maintain adequate protea-
some function in the face of challenges which may compromise
its function or create increased demand for proteasomes. A
homeostatic mechanism controlled by the zinc ﬁnger transcrip-
tion factor Rpn4 is thought to regulate cellular proteasome
abundance [24]. Several recent reports, however, suggest that
regulation of the proteasome may be even more complex. As
opposed to the concerted induction of all proteasome genes
by Rpn4, it now appears that individual components of the
proteasome may be selectively induced under varying cellular
conditions. This induction of speciﬁc proteasome components
has the capacity to alter proteasome function. Thus the protea-
some appears to be under at least two levels of regulatory con-
trol, and both the magnitude and nature of proteasome
function may be altered by the cell to meet varying cellular
requirements.
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activation by Rpn4
Rpn4 was originally identiﬁed in a screen for suppressors of
the temperature sensitivity of a mutant of Sec63, a component
of the endoplasmic reticulum translocon [25]. Because the par-
ticular allele of SEC63 under study was known as npl1-1, the
gene encoding RPN4 was originally designated SON1
(suppressor of npl1-1). Although the mechanistic basis for sup-
pression of the sec63 mutant by loss-of-function in RPN4 re-
mains unclear, two subsequent screens ﬁrmly placed RPN4
within the ubiquitin-proteasome pathway. In the ﬁrst screen,
Varshavsky and co-workers identiﬁed ﬁve yeast genes which,
when mutated, confer defects in the degradation of model pro-
teasome substrates consisting of ubiquitin fusion proteins [26].
Because this pathway is known as the ubiquitin-fusion degra-
dation pathway, SON1 acquired a second designation:
UFD5. An unrelated screen sought yeast mutants that dis-
played synthetic lethality when combined with a mutant of
the proteasome subunit Rpnl2 [27]. Again, mutants of Sonl/
Ufd5 were recovered.
Early studies detected co-fractionation of Sonl/Ufd5 with
other proteasome subunits, and for this reason, the gene was
renamed RPN4 (Regulatory Particle Non-ATPase 4) to reﬂect
its putative role as a subunit of the proteasome [27,28]. Indeed,
Rpn4 appears to make a direct contact with the proteasome
base subunit Rpn2, as recombinant versions of the two pro-
teins interact speciﬁcally [24]. However, later puriﬁcations of
the proteasome failed to identify Rpn4 in signiﬁcant amounts
[29,30]. This discrepancy is likely accounted for by the subse-
quent discovery that Rpn4 is turned over at a rapid rate (its
half-life is estimated to be two minutes or less), and its steady
state abundance is quite low [24].
Analysis of the RPN4 coding sequence identiﬁed sequences
similar to those found in Cys2-His2 zinc ﬁnger domains, as well
as two acidic regions. As both of these features are often found
in transcription factors, a role for Rpn4 in transcription was
investigated. Indeed several groups were able to demonstrate
that Rpn4 acts as a transcription factor, and that a major tar-
get of its transcriptional activity is the proteasome itself
[24,31,32]. Speciﬁcally, an 8–9 nucleotide sequence, known as
Proteasome-Associated Control Element (PACE) can be
found in the upstream promoter regions of all known protea-
some subunits and several proteasome-associating factors, and
it is thought that Rpn4 mediates its eﬀects on proteasome geneFig. 2. Model for distinct cellular pathways mediating the proteasome str
controlled via a negative feedback loop involving the transcription factor
dependent transcriptional regulation of Ubp6, which increases proteasomal e
from Elsevier.transcription by directly binding this element. This observa-
tion, when coupled with data demonstrating that the short
half-life of Rpn4 is a consequence of proteasome-mediated
degradation [24], has led to an elegant model in which Rpn4
controls cellular proteasome levels via a homeostatic negative
feedback loop (Fig. 2).
Several areas of Rpn4 biology remain poorly understood.
Mutations in subunits of the proteasome itself are known to
induce Rpn4 [33,34], consistent with a model in which the
stress response mediated by Rpn4 operates via post-transla-
tional mechanisms. However, it has recently become clear that
the RPN4 gene is itself subject to a complex array of transcrip-
tional controls, indicating that Rpn4 may respond not only to
proteasome dysfunction, but to a variety of cellular stresses,
some or all of which may require an augmentation of protea-
some capacity. The upstream promoter region of RPN4 is rec-
ognized by the heat shock transcription factor Hsﬂ, two
multidrug resistance-associated transcription factors, Pdrl
and Pdr3, as well as the transcription factor Yapl [34–36]. It
remains unclear whether this represents an exhaustive list of in-
puts into RPN4 transcription; likely it does not. Furthermore,
the environmental stresses that activate each of these factors to
induce RPN4 transcription are only beginning to be worked
out. Cellular stresses known to induce RPN4 transcription in-
clude heat, the DNA damaging agent MMS, the amino acid
analog AZC, and hydrogen peroxide [33,34,36]. Yapl, which
is best known for its role in responding to oxidative stress, pre-
sents an unusually interesting case. Not only does Yapl recog-
nize the RPN4 promoter, but the promoter of Yapl itself
contains the PACE box, thus potentially establishing a positive
feedback loop [37]. The full elucidation of environmental in-
puts leading to Rpn4 induction, as well as the cellular factors
carrying out these responses, should add signiﬁcantly to our
understanding of the cellular stress response program.
The outputs of Rpn4 function also remain incompletely
understood. In addition to the proteasome, PACE boxes can
be found in the promoters of more than 20 additional genes
[30,31]. These genes encode a diverse group of factors regulat-
ing processes such as ubiquitination, vacuolar function, RNA
metabolism, and glucose utilization. For the majority of these
genes, it remains unclear to what extent regulation by Rpn4
actually occurs, but their existence suggests the possibility that
proteasome induction may be only one facet of a wide-ranging
cellular stress response mediated by Rpn4. The case of ubiqui-
tination is especially interesting. PACE boxes can be found iness response and the ubiquitin stress response. Proteasome levels are
Rpn4. Ubiquitin levels are controlled, at least in part, via ubiquitin-
ﬃciency in ubiquitin regeneration. Adapted from [54], with permission
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El gene, UBA1, and Rpn4 has been shown to increase UBI4
transcription [31,34]. As proteasome levels rise, ubiquitin
induction may be necessary to support correspondingly higher
rates of degradation. However, at least one report has demon-
strated that supplementation of proteasome hypomorphic mu-
tants with exogenous ubiquitin is actually detrimental [34]. A
related question concerns to what extent proteasomes induced
by Rpn4 resemble their basally-produced counterparts. It has
been long assumed that Rpn4 changes only proteasome num-
ber, but careful studies will be required to exclude the possibil-
ity that proteasomes induced under stress by Rpn4 are actually
adapted in novel ways. Finally, the maximal extent of protea-
some induction by Rpn4 remains unknown. Proteasomes are
highly abundant within cells under unstressed conditions,
and so it seems unlikely that proteasome levels could be ele-
vated by more than an order of magnitude. Recent advances
in constructing mutants of Rpn4 resistant to degradation
[38,39] may be useful in estimating the upper limit of cellular
proteasome plasticity.
A third issue concerns the mechanisms whereby Rpn4 sig-
naling is turned oﬀ, and in particular, the destruction of
Rpn4 protein. Rpn4 is unusual in that despite its extremely
short half-life, a major component of its degradation appears
to be ubiquitin-independent [24]. Accordingly, whereas muta-
tions in the proteasome stabilized Rpn4 against degradation,
global impairment of ubiquitination by mutation of the ubiq-
uitin activating enzyme had no detectable eﬀect on the half-life
of Rpn4 [24]. This puzzling ﬁnding may be explained by the
need for the cell to regulate proteasome and ubiquitin levels
independently (Fig. 2). Thus Rpn4 may have evolved to report
primarily on the activity state of the proteasome, and may be
inherently insensitive to secondary or indirect impairments of
degradation deriving from failure of substrate ubiquitination.
Consistent with this model, while mutations of proteasome
subunits induce Rpn4 accumulation, mutants displaying severe
deﬁciencies of cellular ubiquitin (e.g. doa4D) show no accumu-
lation of Rpn4 [34]. Indeed, it may be that the capacity of
Rpn4 to directly bind the proteasome is necessary for ubiqui-
tin-independent degradation of Rpn4. The situation is made
even more interesting by recent observations that Rpn4 also
undergoes a secondary, but possibly weaker mode of ubiqui-
tin-dependent degradation [38,39]. In this pathway, internal ly-
sines of Rpn4 are recognized and ubiquitinated by the E3
ubiquitin ligase Ubr2 [40]. The signiﬁcance of having both
ubiquitin-dependent and ubiquitin-independent modes of
Rpn4 degradation remains unexplained, and its elucidation
seems fundamental to understanding Rpn4 function.
A ﬁnal open area for investigation into the proteasome stress
response concerns the extension of study into higher eukary-
otes. Thus far, no ortholog of Rpn4 has been identiﬁed in high-
er organisms, nor can PACE boxes be readily recognized in
proteasome genes outside of yeast. Nevertheless, the protea-
some stress response does appear to be conserved in higher
organisms. Studies in both Drosophila and in mammalian cells
have demonstrated that abrogation of proteasome function,
either by treatment with chemical proteasome inhibitors or
by RNAi-treatment directed against proteasome subunits, in-
creased the levels of proteasome gene transcription, and ulti-
mately proteasome levels [41–43]. The identiﬁcation of the
factors required for this response, as well as the promoter se-
quences by which it is mediated, represent important objectivesin understanding the proteasome stress response, and how the
cell regulates proteasome levels to survive cellular stress.4. Regulation of the nature of proteasome function: AIRAP and
Ubp6
The proteasome has traditionally been thought of as a dis-
tinct functional entity, but it is becoming increasingly apparent
that the cell’s population of proteasomes may actually repre-
sent a diverse group of functionally distinct members, and
moreover, that populations of proteasomes may be subject
to highly dynamic regulation. Thus the cell may be able to
not only increase or decrease the abundance of ‘‘canonical’’
proteasome forms, but may also be capable of inducing the
formation of other proteasome conﬁgurations that display no-
vel and unique properties, and which may be useful under
varying cellular conditions.
Early evidence in favor of such a model can be found in the
interferon inducibility of the three core particle subunits har-
boring active sites (known as b1i/LMP2, b2i/MECL1, and
bi/LMP7). Upon transcriptional induction by interferon-c,
these subunits accumulate and are incorporated into the pro-
teasome, replacing their constitutively expressed counterparts
[44]. This modiﬁcation alters proteasome function, resulting
in a spectrum of peptide products that may enhance MHC
Class I-dependent immunological presentation. Also support-
ing the idea of a cellular repertoire of diverse proteasome spe-
cies are the observations that alternate structures besides the
canonical regulatory particle are capable of capping the core
particle. The ﬁrst, known as PA28, is heteroheptameric, is also
inducible by interferon-c, and appears to function with LMP2,
MECL1, and LMP7 to generate optimal substrates for MHC-I
loading and subsequent recognition by the immune system [1].
A second proteasome cap, known as PA200 in mammals and
Blm10 in yeast, consists of a single large (250 kDa) polypep-
tide (see Ref. [5]). How PA200 alters proteasome function re-
mains an open question.
In recent years, two new pathways of proteasome regulation
have become apparent, each mediating response to a distinct
stress. In the ﬁrst, treatment with the toxin arsenic results in
the induction and accumulation of the novel proteasome inter-
actor, AIRAP. In the second, deﬁciencies of cellular ubiquitin
result in the induction and accumulation of the proteasomal
deubiquitinating enzyme Ubp6.5. AIRAP
Arsenic is a naturally occurring compound associated with a
wide variety of adverse eﬀects on human health, and is found
in nature in several forms. The tetraoxide derivative of arsenic
(arsenate; AsO34 ) is capable of substituting for phosphate in
certain phosphoryl transfer reactions. Occurrence of this sub-
stitution during glycolysis, for example, is known to decrease
the yield of ATP from this process [45]. The toxicity of arsenite
ðAsO3 Þ, on the other hand, seems to derive from its ability to
form thiol adducts with free sulfhydryl groups [46]. Such mod-
iﬁcation is thought to promote protein misfolding, and accord-
ingly, arsenite treatment results in both induction of heat
shock responses as well as the accumulation of high molecular
weight ubiquitinated material [47,48].
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small (19 kDa) protein ﬁrst identiﬁed in a screen for genes in-
duced by arsenite treatment [47]. AIRAP shows remarkable
speciﬁcity for the toxicity associated with arsenite, as induction
could not be observed with zinc, copper, tunicamycin, thapsi-
gargin, hydrogen peroxide, heat, or AZC [47,49]. Failure of
induction by AZC, a proline analog which promotes protein
misfolding, seems particularly interesting because of the sus-
pected role of protein misfolding in arsenite toxicity. The eﬃ-
cacy of AIRAP induction is clear inasmuch as experimentally
induced deﬁciencies in AIRAP give rise to markedly increased
death rates of C. elegans exposed to arsenite [47].
An initial report suggested a role for AIRAP in binding
RNA [47]. The signiﬁcance of this result remains unclear, par-
ticularly in light of a second report which indicated a robust
role for AIRAP in proteasome function [49]. Under arsenite-
free conditions, low levels of AIRAP appear to be associated
with proteasomes, but in the presence of arsenite, AIRAP
can be readily co-puriﬁed with proteasomes. That these AIR-
AP-containing proteasomes are distinct from basally produced
proteasomes was immediately suggested by the imprecise co-
fractionation of AIRAP and canonical proteasome subunits.
Speciﬁcally, AIRAP-containing proteasomes appear to repre-
sent a heavier-than-average subpopulation of the total protea-
some pool [49]. In vivo, total cellular ubiquitin conjugate levels
increased in cells treated with an siRNA directed against AIR-
AP, consistent with the proposed role of AIRAP in protea-
some function. The exact role of AIRAP in proteasome
function remains unclear, but in vitro, AIRAP has intriguing
eﬀects on proteasome stability. Conventionally puriﬁed pro-
teasomes require ATP, at least in part, for prolonged integrity.
In contrast, proteasomes containing AIRAP were not only sta-
ble in the absence of ATP, but actually appeared to disassem-
ble in the presence of ATP [49]. Furthermore, AIRAP-
containing proteasomes showed higher rates of hydrolysis of
model substrates such as the peptide substrate suc-LLVY-
AMC, a property possibly related to the increased in vitro pro-
teasome stability conferred by AIRAP [49]. Notably, arsenic
itself had little eﬀect on the ability of puriﬁed proteasomes to
hydrolyze suc-LLVY-AMC, suggesting that the function of
AIRAP may be to adapt proteasomes to withstand an as yet
poorly understood cellular toxicity arising secondary to arsenic
exposure.
What might be the function of AIRAP? Sequence analysis
indicates two regions containing highly conserved cysteine
and histidine residues, and proteasome binding by AIRAP re-
quires at least the C-terminal cysteine/histidine repeat [49]. The
precise arrangement of the conserved residues bears similarities
to the RING domain which is often found in ubiquitin ligases
[49]. Ubiquitination at the proteasome is known to increase the
eﬃciency of proteasome-mediated degradation [19]. Possibly,
AIRAP works analogously to improve proteasome eﬃciency
in the face of an increased substrate burden arising from pro-
tein modiﬁcation by arsenite. However, such a model would be
unlikely to explain the increased capacity of proteasomes to
degrade model substrates like suc-LLVY-AMC, which are
hydrolyzed in a ubiquitin-independent manner. Alternatively,
the nucleotide-independent stability of proteasomes conferred
by AIRAP may protect proteasomes against the ATP deplet-
ing eﬀects of arsenic forms including arsenate. Though not
excluding this model, the levels of arsenic necessary for AIR-
AP induction are signiﬁcantly lower than those required to de-plete cellular ATP [49]. A third model posits that AIRAP
might in fact represent a functional homolog of Rpn4. The
arrangement of conserved cysteines and histidines in AIRAP
does not obviously resemble the Cys2–His2 sequence of
Rpn4. However, arsenic is known to induce a proteasome
stress response [50], AIRAP does appear to make contacts
within the base of the proteasome adjacent to the site of
Rpn4-proteasome interaction [49], and AIRAP, despite its
speciﬁcity for arsenic, is also induced by MMS, a potent stim-
ulus of Rpn4 induction [49]. The elucidation of the precise
function of AIRAP will likely require an exploration of AIR-
AP’s eﬀects on the various functions carried out by the protea-
some, namely substrate recognition, unfolding,
deubiquitination (and possibly ubiquitination), opening of
the gate into the CP, translocation of substrate into the CP,
and ﬁnally, proteolysis.6. Ubp6
Ubp6, along with Rpn11, is one of two deubiquitinating en-
zymes associated with proteasomes of budding yeast. Higher
eukaryotes possess yet a third proteasomal deubiquitinating
enzyme, Uch37. The precise roles of these three deubiquitinat-
ing enzymes in proteasome-mediated degradation, their sub-
strate speciﬁcity, and their relationships with one another
remain incompletely understood. Nevertheless, current studies
point to proteasome-mediated deubiquitination as a particu-
larly complex aspect of the ubiquitin-proteasome pathway.
Deubiquitination by Rpn11 is thought to facilitate substrate
degradation because mutations in the active site of Rpn11 sta-
bilize various substrates in vitro and in vivo [20,21]. In con-
trast, Uch37 appears to negatively regulate proteasome-
mediated degradation [51]. Recognition of substrates by the
proteasome generally requires previous modiﬁcation of the
substrate by ubiquitin, and increased levels of ubiquitin mod-
iﬁcation appear to increase aﬃnity of the substrate for the pro-
teasome, possibly by allowing for greater interaction of the
substrate with proteasomal ubiquitin receptors. Thus, prema-
ture removal of these ubiquitin molecules could thwart sub-
strate degradation by decreasing substrate aﬃnity for the
proteasome. Uch37 is capable of slowing degradation in this
manner, although just why Uch37 has evolved to accomplish
this remains unclear. One plausible model is that Uch37 serves
as an ‘‘editing’’ enzyme for ubiquitin conjugates, biasing deg-
radation towards more highly ubiquitinated substrates [51].
Such a system could correct for ‘‘errors’’ in ubiquitination,
in which inappropriate substrates have been aberrantly recog-
nized by the ubiquitin system, but only modestly ubiquitinated
due to a low aﬃnity for the ubiquitin ligase. A second model
posits that the nature of ubiquitin signals may inherently pri-
oritize substrates. Substrates that acquire long ubiquitination
chains in a single round of interaction with a ubiquitin ligase
(termed ‘‘processive’’ ubiquitination) may be degraded more
quickly than substrates that require multiple rounds of interac-
tion with their ubiquitin ligase (termed ‘‘distributive’’ ubiquiti-
nation), the diﬀerence in rates of degradation being accounted
for by increased susceptibility of distributive substrates to
deubiquitination [52]. Possibly, Uch37 functions to orchestrate
such ordering of degradation rates.
The third deubiquitinating enzyme, Ubp6, also appears to
inhibit proteasome-mediated degradation [53]. However, in
Fig. 3. Model for dual modes of ubiquitin regeneration by Ubp6. The
primary eﬀect of Ubp6 on ubiquitin levels is mediated by the catalytic
deubiquitinating activity of Ubp6. However, Ubp6 also appears to
directly inhibit the proteasome via non-catalytic functions, and this
slowing of total ﬂux through the proteasome might provide a second
mechanism for ubiquitin stabilization.
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its capacity for proteasome inhibition both in vitro and in vivo
[53,54]. Thus, Ubp6 has both deubiquitinating activity and
proteasome-inhibitory activity. Presumably, these two func-
tions are coordinated in Ubp6’s overall activity, but direct evi-
dence on this point is lacking. The catalytic activity of Ubp6 is
crucial in controlling cellular levels of ubiquitin. In the absence
of Ubp6’s catalytic activity, the rate of ubiquitin degradation
increases dramatically, and this degradation occurs via the
proteasome [30,53,55,56]. Thus, Ubp6 functions in regenerat-
ing ubiquitin from ubiquitin conjugates, and when this does
not occur, ubiquitin is apparently translocated into the core
particle along with substrate and destroyed. The physiologic
signiﬁcance of Ubp6 function is highlighted not only by the
many stress hypersensitivities of ubp6 mutants [55,56], but by
the ataxia mouse, which derives from loss-of-function muta-
tions in murine Ubp6, known as Usp14 [57]. This mouse is
subject to a broad array of neurologic dysfunctions, and uni-
formly undergoes premature death.
The exact stoichiometry of Ubp6 with respect to the protea-
some remains an unsettled question, but Ubp6 is visible by
conventional Coomassie staining in standard preparations of
wild-type proteasomes, indicating that it is an abundant pro-
teasome component under steady-state conditions [30]. Indeed,
Ubp6 contains a PACE sequence [30] and is co-regulated with
other proteasome subunits by Rpn4 [42,54], but a recent study
indicates that Ubp6 is subject to additional modes of regula-
tion outside of the proteasome stress response [54].
An initial insight came from examination of cellular levels of
Ubp6 and the catalytically dead mutant, ubp6-C118A, when
expressed from the UBP6 promoter. Ubp6-C118A accumu-
lated to signiﬁcantly higher levels than the wild-type protein
[54]. Because Ubp6-C118A is devoid of catalytic activity,
and because the catalytic activity of Ubp6 is necessary to
maintain ubiquitin levels, it was hypothesized that accumula-
tion of Ubp6-C118A might reﬂect a cellular stress response de-
signed to correct ubiquitin levels. Indeed, when ubiquitin
levels were corrected by exogenous expression of ubiquitin,
levels of Ubp6-C118A were restored to nearly wild-type levels
[54]. Furthermore, accumulation of wild-type Ubp6 protein
could be observed in multiple unrelated yeast mutants deﬁ-
cient in cellular ubiquitin levels, suggesting that ubiquitin-
dependent induction of Ubp6 represents a physiologic cellular
stress response [54]. In every case, induction of Ubp6 or Ubp6-
C118A protein was accompanied by increased transcription of
the respective gene, analogous to the situation of AIRAP [54].
Importantly, and again likewise for AIRAP, induction of
Ubp6 in response to ubiquitin deﬁciency resulted in increased
loading of proteasome with Ubp6 or Ubp6-C118 A. Because
of the speciﬁc proteasomal enrichment of Ubp6, and because
ubiquitin deﬁciency does not seem to necessarily stimulate
Rpn4 accumulation (34, 54), this pathway of ubiquitin-depen-
dent induction of Ubp6 has been termed the ‘‘ubiquitin stress
response’’ to distinguish it from the proteasome stress re-
sponse (Fig. 2).
Several important aspects of the ubiquitin stress response re-
main poorly understood. The cis-acting element within the
UBP6 promoter, as well as the factors that mediate recognition
of this element, remain unknown. Furthermore, the physio-
logic eﬃcaciousness of Ubp6 induction remains unexamined.
Does ubiquitin-dependent induction of Ubp6 truly buﬀer ubiq-
uitin levels against stress? Identiﬁcation of the ubiquitin-regu-lated element within the UBP6 promoter should allow for
rigorous testing of this model.
A second question concerns the mechanisms whereby Ubp6
contributes to ubiquitin homeostasis. Without doubt, the
majority of ubiquitin sparing mediated by Ubp6 is catalytic
in nature, as ubp6-C118A mutants display serious ubiquitin
deﬁciencies, and recapitulate the null phenotype when chal-
lenged with various ubiquitin-dependent stresses [53]. How-
ever, Ubp6 also mediates a non-catalytic inhibition of
proteasome-mediated degradation, and such inhibition does
not appear to be highly restricted in the scope of its substrates
[54]. Thus, Ubp6 may contribute a second, indirect eﬀect on
ubiquitin levels via a decreased overall ﬂux of ubiquitin conju-
gates through the proteasome. Such a model predicts that
ubiquitin levels in the ubp6-C118A mutant should be at least
modestly elevated compared to the null mutant (Fig. 3). Visual
inspection of the data [54] suggests that this may indeed be the
case, but careful quantitations will be required.
A third question concerns the provenance of increased Ubp6
levels on proteasomes. Transcriptional induction of the UBP6
gene may account for the entire diﬀerence in Ubp6 levels on
proteasomes. However, it should be noted that several groups
have reported minor, yet signiﬁcant, non-proteasomal pools of
Ubp6 in cells [56,58]. Whether proteasomes can recruit addi-
tional Ubp6 from these pools remains an intriguing open ques-
tion. Indeed, such a scenario would allow for more rapid
induction of the stress response.
It is also worth exploring why the ubiquitin stress response
appears to be distinct from the proteasome stress response,
especially as the latter has components of ubiquitin regulation
in addition to proteasome regulation [31,34]. It is thought that
the majority of degradation mediated by the proteasome pro-
ceeds via ubiquitination of substrates. Thus, under conditions
of proteasome induction, it may be necessary to provide corre-
sponding increases of ubiquitin levels, which might be achieved
primarily through induction of the polyubiquitin gene, UBI4
[34]. It remains unclear whether an increased UBI4 mRNA le-
vel actually elevates cellular ubiquitin pools, as opposed to
ameliorating attrition of these pools, and indeed, artiﬁcially
raising ubiquitin levels during proteasome stress actually exac-
erbates the phenotypes of some proteasome mutants [34]. On
the other hand, it must be appreciated that ubiquitin performs
an astounding array of cellular tasks independent of the pro-
teasome, including regulation of cell surface receptors, his-
tones, membrane traﬃcking, transcription, and DNA repair,
to name a few [59]. All of these ubiquitin-dependent processes
may be subject to some degree of dysfunction when ubiquitin
levels fall. Thus, it may be advantageous for cells to be able to
2860 J. Hanna, D. Finley / FEBS Letters 581 (2007) 2854–2861control ubiquitin levels separately from proteasome levels. In-
deed, even in wild-type cells, some fraction of ubiquitin is de-
graded by proteasomes [54,56,60]. Raising proteasome levels
under conditions of ubiquitin deﬁciency might actually exacer-
bate the deﬁciency by increasing basal rates of ubiquitin degra-
dation.
A ﬁnal point of intrigue derives from the interesting conver-
gence of AIRAP and Ubp6 onto a single proteasome subunit,
Rpnl. Ubp6 and Rpnl directly interact in their bacterially pro-
duced, puriﬁed forms [30]. In the case of AIRAP, speciﬁc
crosslinking to Rpnl/PSMD2 has been observed, and bacteri-
ally produced, puriﬁed AIRAP is bound by extract-derived
Rpnl [49]. Possibly, these ﬁndings represent coincidence, but
it is tempting to speculate on the function of Rpnl. Rpnl and
Rpn2, two of the largest subunits of the proteasome, are re-
lated in sequence, and are thought to occupy a central position
in the RP, between the ring of six ATPases in the base and the
subunits of the lid. Furthermore, Rpnl and Rpn2 are known to
bind a number of substoichiometric or more loosely-binding
components of the proteasome including not only AIRAP
and Ubp6, but also the ubiquitin receptors Rad23 andDsk2
[17,18], and the ubiquitin conjugating enzyme, Hul5 (KIAA10
in mammals) whose function appears to be highly related to
that of Ubp6 [19]. Thus Rpnl and Rpn2 may represent a scaf-
fold for the assembly of a variety of factors which can modu-
late the nature of ubiquitin chain processing and substrate
degradation. Possibly, the array of factors bound to Rpnl
and Rpn2 may be variable and highly dynamic, such that Rpnl
and Rpn2 may serve as an ‘‘expansion port’’ for the protea-
some – a speciﬁc site at which subunit-speciﬁc proteasome
remodeling occurs.7. Concluding remarks
The term ‘‘proteasome’’ is often utilized in such a way as to
imply a uniformity of form and function. However, it has be-
come increasingly clear from recent studies that the cell’s pop-
ulation of proteasomes may actually represent a diverse group
of functionally distinct entities, and furthermore, the capacity
to convert between forms as well to generate novel forms may
be highly developed and subject to sophisticated modes of reg-
ulation. The versatility of the proteasome and its capacity for
regulation in both magnitude and nature likely play key roles
in the ability of cells to survive a wide variety of environmental
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